David Schaffer is Director of 4D Molecular Therapeutics, Inc.. Currently has a direct ownership of 901,215 shares of FDMT, which is worth approximately $5 Million. The most recent transaction as insider was on Oct 22, 2021, when has been sold 1,900 shares (Common Stock) at a price of $31.0 per share, resulting in proceeds of $58,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 901K
0% 3M change
0% 12M change
Total Value Held $5 Million

DAVID SCHAFFER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 22 2021
SELL
Open market or private sale
$58,900 $31.0 p/Share
1,900 Reduced 0.21%
901,215 Common Stock
Oct 21 2021
SELL
Open market or private sale
$720,199 $31.56 p/Share
22,820 Reduced 2.46%
903,115 Common Stock
Oct 20 2021
SELL
Open market or private sale
$358,746 $31.02 p/Share
11,565 Reduced 1.23%
925,935 Common Stock
Sep 30 2021
SELL
Open market or private sale
$334,271 $26.99 p/Share
12,385 Reduced 1.3%
937,500 Common Stock
Sep 29 2021
SELL
Open market or private sale
$489,934 $29.04 p/Share
16,871 Reduced 1.75%
949,885 Common Stock
Sep 28 2021
SELL
Open market or private sale
$434,889 $31.26 p/Share
13,912 Reduced 1.42%
966,756 Common Stock
Sep 27 2021
SELL
Open market or private sale
$646,269 $33.43 p/Share
19,332 Reduced 1.93%
980,668 Common Stock
DS

David Schaffer

Director
Emeryville, CA

Track Institutional and Insider Activities on FDMT

Follow 4D Molecular Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FDMT shares.

Notify only if

Insider Trading

Get notified when an 4 D Molecular Therapeutics, Inc. insider buys or sells FDMT shares.

Notify only if

News

Receive news related to 4D Molecular Therapeutics, Inc.

Track Activities on FDMT